This proposal from the Medical University of South Carolina (MUSC) and the Rollings Cancer Center requests support for an interdisciplinary research training program in cancer therapeutics for postdoctoral fellows. It is designed to train promising young scientists with backgrounds in the biomedical sciences with special emphasis on the management of cancer and the experimental strategies, approaches, and technologies necessary to develop novel therapeutics targeting specific cancers. Future decades will undoubtedly see even more rapid advances in our understanding of the structure and function of molecules (both chemical and biological) involved in cancer therapy. Successful application of these insights will permit development of novel therapeutic approaches to the treatment and prevention of cancer. Such advances will require well-trained, energetic, and productive scientists with the ability to understand and manipulate molecular events within a physiological context. These are the type of individuals we aim to develop through the integrated postdoctoral components of this training program. The Mentor-eligible Faculty Members were selected based on their research interests related to cancer therapeutics, active NIH research support, ongoing collaborations, successful training and mentoring experience, and commitment to postdoctoral training. The 24 members include 18 professors, 2 associate professors, and 4 assistant professors. They have strong publication records and are well funded. Nineteen (80%) hold NCI research grants. They represent 9 departments in 2 colleges (Biochemistry, Biostatistics, Cell Biology, Medicine, Microbiology, Pathology, Pharmacology, and Surgery in the College of Medicine, and Pharmaceutical Sciences in the College of Pharmacy). The Program Director and co-Director are assisted by a Program Steering Committee and an External Advisory Committee of outstanding experts in the field of small molecule and gene therapy. Key components of the training program are the mentored research experience, a required course providing a broad perspective of cancer, required training in responsible conduct of research, elective courses, journal clubs, seminars, presentations at regional and national conferences, and professional development activities. Program evaluation is a strength of the training program.
| Robichaux 3rd, William G; Branham-O'Connor, Melissa; Hwang, Il-Young et al. (2017) Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4). J Pharmacol Exp Ther 360:424-433 |
| Peterson, Yuri K; Cameron, Robert B; Wills, Lauren P et al. (2013) ?2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis. Bioorg Med Chem Lett 23:5376-81 |
| Turner-Ivey, B; Manevich, Y; Schulte, J et al. (2013) Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer. Oncogene 32:5302-14 |
| Hance, Michael W; Dole, Krystal; Gopal, Udhayakumar et al. (2012) Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. J Biol Chem 287:37732-44 |
| Wills, Lauren P; Trager, Richard E; Beeson, Gyda C et al. (2012) The ?2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther 342:106-18 |
| Wills, Lauren P; Schnellmann, Rick G (2011) Telomeres and telomerase in renal health. J Am Soc Nephrol 22:39-41 |
| Turner, L S; Cheng, J C; Beckham, T H et al. (2011) Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide. Prostate Cancer Prostatic Dis 14:30-7 |
| Mack, Jody T; Helke, Kristi L; Normand, Gabrielle et al. (2011) ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration. Cancer Lett 300:154-61 |
| Wills, Lauren P; Schnellmann, Rick G (2010) Telomere shortening and regenerative capacity after acute kidney injury. J Am Soc Nephrol 21:202-4 |
| Grek, Christina L; Tew, Kenneth D (2010) Redox metabolism and malignancy. Curr Opin Pharmacol 10:362-8 |
Showing the most recent 10 out of 11 publications
